Methyl 2-fluoro-5-hydroxy-4-methylbenzoate
CAS: 1378655-77-6
Ref. 3D-DFC65577
| 1g | Discontinued | ||
| 5g | Discontinued | ||
| 10g | Discontinued | ||
| 100mg | Discontinued | ||
| 250mg | Discontinued | ||
| 500mg | Discontinued |
Product Information
- 2-Fluoro-5-hydroxy-4-methyl-benzoic acid methyl ester
- Methyl 5-Bromo-2-Fluoro-4-Methylbenzoate
- Benzoic acid, 4-me-2-fluoro-5-bromo-, methylester
- Methyl2-fluoro-5-hydroxy-4-methylbenzoate
- 2-Fluoro-5-hydroxy-4-methylbenzoic acid methyl ester
Methyl 2-fluoro-5-hydroxy-4-methylbenzoate is a preclinical drug that is an antagonist of calcitonin, which is a hormone that regulates calcium. It has been shown to have enantioselective properties and to be an effective inhibitor of the calcitonin receptor. Methyl 2-fluoro-5-hydroxy-4-methylbenzoate has also been shown to decrease the activity of a particular type of protein kinase C by inhibiting the production of peptides related to this receptor. The synthesis of methyl 2-fluoro-5-hydroxy-4-methylbenzoate can be achieved in two steps from methyl 4,6,6a,7b,8a,9,10,10a-octahydroanthracene carboxylate. This compound has been shown to have pharmacophore properties that are similar to those seen in other drugs used for the treatment of osteop
